PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE

PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.049 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy 01 - Articolo su rivista 2024 Pieruzzi F. +
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice 01 - Articolo su rivista 2024 Pieruzzi F. +
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 01 - Articolo su rivista 2024 Pieruzzi, F +
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 01 - Articolo su rivista 2024 Peiti S.Magatti M. G.Trezzi B.Contaldo G.Pieruzzi F.Ruggenenti P.Battaglino G. +
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 01 - Articolo su rivista 2024 Cazzaniga, GiorgioDel Carro, FabioPieruzzi, FedericoPagni, FabioL'Imperio, Vincenzo +
Interpretation of GFR slope in untreated and treated adult Fabry patients 01 - Articolo su rivista 2024 Pieruzzi, Federico +
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 01 - Articolo su rivista 2024 Lucchini, AlbertoPieruzzi, FedericoElli, Stefano +
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 01 - Articolo su rivista 2024 Fabbrini P.Vergani D.Malinverno A.Pieruzzi F. +
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 01 - Articolo su rivista 2024 Pieruzzi, Federico +
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 01 - Articolo su rivista 2023 Pieruzzi F. +
Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis 01 - Articolo su rivista 2023 Pieruzzi, Federico +
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 01 - Articolo su rivista 2023 Genovesi, SRebora, PPieruzzi, F +
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan 01 - Articolo su rivista 2023 Pieruzzi F. +
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 01 - Articolo su rivista 2023 Battaglino G.Ruggenenti P.Stefani F. S.Pieruzzi F.Contaldo G.Trezzi B.Magatti M. G.Peiti S.Pezzini E. +
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial 01 - Articolo su rivista 2023 Pieruzzi F. +
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease 01 - Articolo su rivista 2022 Pieruzzi F. +
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 99 - Altro 2022 Salerno F. R.Roggero L.Binaggia A.Pieruzzi F. +
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 01 - Articolo su rivista 2022 Lacetera R.Roggero L.Vercelloni P.Uzzo M.Carbone M.Invernizzi P.L'Imperio V.Pieruzzi F.Sinico R. A.
Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy 01 - Articolo su rivista 2022 Pieruzzi F. +
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 01 - Articolo su rivista 2022 Pieruzzi F. +